Literature DB >> 11572036

Primary aldosteronism: are we diagnosing and operating on too few patients?

R D Gordon1, M Stowasser, J C Rutherford.   

Abstract

Many cases of potentially curable primary aldosteronism are currently likely to be diagnosed as essential hypertension unless screening tests based on suppression of renin are carried out in all hypertensive patients. More than half of the patients with primary aldosteronism detected in this way have normal circulating potassium levels, so measurement of potassium is not enough to exclude primary aldosteronism. When primary aldosteronism is diagnosed, fewer than one-third of patients are suitable for surgery as initial treatment, but this still represents a significant percentage of hypertensive patients. After excluding glucocorticoid-suppressible primary aldosteronism, adrenal venous sampling is essential to detect unilateral production of aldosterone and diagnose angiotensin-responsive aldosterone-producing adenoma. One cannot rely on the computed tomography scan. If all hypertensive patients are screened for primary aldosteronism and the workup is continued methodically in those with a positive screening test, patients with unilateral overproduction of aldosterone who potentially can be cured surgically are not denied the possibility of cure.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11572036     DOI: 10.1007/s00268-001-0033-4

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  31 in total

Review 1.  Primary aldosteronism.

Authors:  R D Gordon
Journal:  J Endocrinol Invest       Date:  1995 Jul-Aug       Impact factor: 4.256

2.  Preoperative lateralisation of aldosterone-producing tumours in primary aldosteronism.

Authors:  B A Scoggins; C J Oddie; W S Hare; J P Coghlan
Journal:  Ann Intern Med       Date:  1972-06       Impact factor: 25.391

3.  Diagnosis and localization of aldosterone-producing adenomas by adrenal-vein cateterization.

Authors:  J C Melby; R F Spark; S L Dale; R H Egdahl; P C Kahn
Journal:  N Engl J Med       Date:  1967-11-16       Impact factor: 91.245

4.  Production of 18-oxo-cortisol in subtypes of primary aldosteronism.

Authors:  M Stowasser; A W Bachmann; T J Tunny; R D Gordon
Journal:  Clin Exp Pharmacol Physiol       Date:  1996 Jun-Jul       Impact factor: 2.557

5.  Success of surgery for primary aldosteronism judged by residual autonomous aldosterone production.

Authors:  J C Rutherford; W L Taylor; M Stowasser; R D Gordon
Journal:  World J Surg       Date:  1998-12       Impact factor: 3.352

6.  Response to unilateral adrenalectomy for aldosterone-producing adenoma: effect of potassium levels and angiotensin responsiveness.

Authors:  M Stowasser; S A Klemm; T J Tunny; W J Storie; J C Rutherford; R D Gordon
Journal:  Clin Exp Pharmacol Physiol       Date:  1994-04       Impact factor: 2.557

7.  A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension.

Authors:  R P Lifton; R G Dluhy; M Powers; G M Rich; S Cook; S Ulick; J M Lalouel
Journal:  Nature       Date:  1992-01-16       Impact factor: 49.962

8.  A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Results in hypertensive patients.

Authors:  K Hiramatsu; T Yamada; Y Yukimura; I Komiya; K Ichikawa; M Ishihara; H Nagata; T Izumiyama
Journal:  Arch Intern Med       Date:  1981-11

9.  A new genetic test for familial hyperaldosteronism type I aids in the detection of curable hypertension.

Authors:  J R Jonsson; S A Klemm; T J Tunny; M Stowasser; R D Gordon
Journal:  Biochem Biophys Res Commun       Date:  1995-02-15       Impact factor: 3.575

View more
  9 in total

1.  Visualization of the right adrenal vein using CT during right inferior phrenic arteriography in hepatocellular carcinoma patients.

Authors:  Sota Oguro; Seishi Nakatsuka; Masahiro Jinzaki; Manabu Misu; Hideki Yashiro; Subaru Hashimoto; Sachio Kuribayashi
Journal:  Jpn J Radiol       Date:  2014-09-24       Impact factor: 2.374

Review 2.  Primary aldosteronism: diagnostic and therapeutic considerations.

Authors:  Mari K Nishizaka; David A Calhoun
Journal:  Curr Cardiol Rep       Date:  2005-11       Impact factor: 2.931

Review 3.  [Modern pharmacological aspects of hyperaldosteronism therapy].

Authors:  M Quinkler; M Reincke
Journal:  Internist (Berl)       Date:  2006-09       Impact factor: 0.743

4.  What is the role of aldosterone excess in resistant hypertension and how should it be investigated and treated?

Authors:  Domenic A Sica
Journal:  Curr Cardiol Rep       Date:  2011-12       Impact factor: 2.931

Review 5.  Diagnosis and management of primary aldosteronism.

Authors:  Malcolm H Wheeler; Dean A Harris
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

6.  The role of adrenal venous sampling in the surgical management of primary aldosteronism.

Authors:  Antonio Toniato; Paolo Bernante; Gian Paolo Rossi; Maria Rosa Pelizzo
Journal:  World J Surg       Date:  2006-04       Impact factor: 3.282

Review 7.  Topical Diagnosis and Determination of the Primary Hyperaldosteronism Variant.

Authors:  Viktor O Shidlovskyi; Olexandr V Shidlovskyi; Oleksandr A Tovkai; Michael I Sheremet; Vitaliy V Maksymyuk; Volodimir V Tarabanchuk; Shved M Ivanovych; Mykolaivna S Heryak; Mykhailovych S Andreychyn; Igorivna I Hanberher; Antonina A Piddubna
Journal:  J Med Life       Date:  2019 Oct-Dec

Review 8.  Aldosteronoma.

Authors:  Laurent Brunaud; Quan-Yang Duh
Journal:  Curr Treat Options Oncol       Date:  2002-08

Review 9.  Laboratory Diagnostics of Primary Hyperaldosteronism and its Peculiarities (Literature Review).

Authors:  Viktor O Shidlovskyi; Oleander V Shidlovskyi; Mikhail Sheremet; Igor V Zhulkevych; Sergyi M Andreychyn; Inna I Hanberher; Ivan I Smachylo; Volodimir B Dobrorodny; Yuryi M Futuima
Journal:  J Med Life       Date:  2019 Jul-Sep
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.